Free Trial
→ This Crypto Is Set to Explode in January (From Crypto 101 Media) (Ad) Buy CLBT Stock  Free CLBT Stock Alerts

Cellebrite DI (CLBT) Financials

Cellebrite DI logo
$19.06 +0.67 (+3.64%)
Closing price 04/23/2025 04:00 PM Eastern
Extended Trading
$19.44 +0.38 (+1.99%)
As of 04/23/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Cellebrite DI

Annual Income Statements for Cellebrite DI

This table shows Cellebrite DI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -1.88 5.78 71 121 -81 -283
Consolidated Net Income / (Loss)		 -1.88 5.78 71 121 -81 -283
Net Income / (Loss) Continuing Operations		 -1.88 5.78 71 121 -81 -283
Total Pre-Tax Income 		1.42 11 82 121 -76 -276
Total Operating Income		 -1.52 9.22 14 1.04 33 57
Total Gross Profit		 136 157 204 220 272 339
Total Revenue		 172 195 246 271 325 401
Operating Revenue		 172 195 246 271 325 401
Total Cost of Revenue		 36 38 43 51 53 63
Operating Cost of Revenue		 36 38 43 51 53 63
Total Operating Expenses		 138 148 190 219 239 282
Selling, General & Admin Expense		 29 32 48 41 43 51
Marketing Expense		 62 61 76 97 111 132
Research & Development Expense		 47 54 66 81 84 98
Total Other Income / (Expense), net		 2.94 2.18 68 120 -109 -333
Other Income / (Expense), net		 2.94 2.18 68 120 -109 -333
Income Tax Expense		 3.29 5.62 11 -0.05 5.54 7.02
Basic Earnings per Share		 ($0.08) ($0.08) $0.49 $0.64 ($0.43) ($1.35)
Weighted Average Basic Shares Outstanding		 121.56M 123.70M 144.00M 182.69M 190.15M 209.47M
Diluted Earnings per Share		 ($0.08) ($0.08) $0.44 $0.59 ($0.43) ($1.35)
Weighted Average Diluted Shares Outstanding		 121.56M 123.70M 161.54M 195.39M 190.15M 209.47M
Weighted Average Basic & Diluted Shares Outstanding		 - - 188.54M 205.30M - 239.47M

Quarterly Income Statements for Cellebrite DI

No quarterly income statements for Cellebrite DI are available.

Annual Cash Flow Statements for Cellebrite DI

This table details how cash moves in and out of Cellebrite DI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 45 51 13 -57 101 3.35
Net Cash From Operating Activities		 16 67 36 21 102 132
Net Cash From Continuing Operating Activities		 16 67 36 21 102 132
Net Income / (Loss) Continuing Operations		 -1.88 5.78 71 121 -81 -283
Consolidated Net Income / (Loss)		 -1.88 5.78 71 121 -81 -283
Depreciation Expense		 4.08 5.88 7.01 9.19 10 11
Amortization Expense		 - 0.00 0.00 -0.37 -1.11 -2.90
Non-Cash Adjustments To Reconcile Net Income		 13 7.96 -61 -105 131 370
Changes in Operating Assets and Liabilities, net		 1.17 47 19 -3.92 43 38
Net Cash From Investing Activities		 -47 -6.45 45 -91 -23 -149
Net Cash From Continuing Investing Activities		 -47 -6.45 45 -91 -23 -149
Purchase of Property, Plant & Equipment		 -6.21 -6.18 -5.11 -6.90 -5.23 -8.57
Acquisitions		 0.00 -15 -23 -2.19 -2.69 -4.79
Purchase of Investments		 -41 -139 -21 -165 -144 -335
Sale and/or Maturity of Investments		 - 153 94 83 130 199
Net Cash From Financing Activities		 76 -8.59 -68 14 22 21
Net Cash From Continuing Financing Activities		 76 -8.59 -68 14 22 21
Issuance of Common Equity		 - 0.00 0.00 1.34 2.62 3.34
Other Financing Activities, net		 0.14 1.49 32 13 19 17
Cash Income Taxes Paid		 3.00 2.91 8.16 9.05 10 7.71

Quarterly Cash Flow Statements for Cellebrite DI

No quarterly cash flow statements for Cellebrite DI are available.

Annual Balance Sheets for Cellebrite DI

This table presents Cellebrite DI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets		 364 340 403 533 691
Total Current Assets		 324 273 296 422 568
Cash & Equivalents		 129 146 88 190 192
Short-Term Investments		 - 0.00 45 39 102
Accounts Receivable		 66 68 79 77 82
Inventories, net		 4.75 6.51 10 9.94 8.94
Prepaid Expenses		 7.44 13 17 26 23
Other Current Assets		 112 40 58 80 160
Plant, Property, & Equipment, net		 16 17 17 16 17
Total Noncurrent Assets		 24 50 90 95 106
Long-Term Investments		 - 0.00 22 29 37
Goodwill		 9.46 27 27 27 29
Intangible Assets		 6.61 11 11 11 11
Noncurrent Deferred & Refundable Income Taxes		 7.37 9.80 13 7.02 11
Other Noncurrent Operating Assets		 0.57 1.96 17 22 18
Total Liabilities & Shareholders' Equity		 364 340 403 533 691
Total Liabilities		 199 413 329 499 355
Total Current Liabilities		 159 187 208 254 296
Accounts Payable		 54 64 50 53 74
Current Deferred Revenue		 106 123 153 196 217
Other Current Liabilities		 - 0.00 5.00 4.97 4.13
Total Noncurrent Liabilities		 40 227 122 245 59
Noncurrent Deferred Revenue		 33 36 42 47 45
Other Noncurrent Operating Liabilities		 6.19 190 79 198 14
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 64 -73 74 34 336
Total Preferred & Common Equity		 64 -73 74 34 336
Total Common Equity		 64 -73 74 34 336
Common Stock		 34 -153 -126 -85 499
Retained Earnings		 28 78 199 118 -165
Treasury Stock		 -0.09 -0.09 -0.09 -0.09 -0.09
Accumulated Other Comprehensive Income / (Loss)		 1.32 1.37 0.33 1.05 2.09

Quarterly Balance Sheets for Cellebrite DI

No quarterly balance sheets for Cellebrite DI are available.

Annual Metrics and Ratios for Cellebrite DI

This table displays calculated financial ratios and metrics derived from Cellebrite DI's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 13.42% 26.34% 9.91% 20.12% 23.41%
EBITDA Growth		 0.00% 214.45% 416.97% 45.09% -151.44% -302.47%
EBIT Growth		 0.00% 705.44% 622.16% 46.72% -162.57% -265.24%
NOPAT Growth		 0.00% 132.02% 156.43% -91.29% 2,127.70% 71.21%
Net Income Growth		 0.00% 408.16% 1,135.01% 69.20% -167.13% -248.96%
EPS Growth		 0.00% 0.00% 650.00% 34.09% -172.88% -213.95%
Operating Cash Flow Growth		 0.00% 312.26% -45.79% -42.92% 395.98% 29.51%
Free Cash Flow Firm Growth		 0.00% 0.00% 1,090.94% -152.47% 220.22% -214.13%
Invested Capital Growth		 0.00% 0.00% -803.78% 63.27% -176.68% 102.67%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 79.16% 80.57% 82.72% 81.25% 83.63% 84.40%
EBITDA Margin		 3.20% 8.86% 36.27% 47.88% -20.50% -66.87%
Operating Margin		 -0.88% 4.73% 5.61% 0.39% 10.22% 14.18%
EBIT Margin		 0.82% 5.85% 33.42% 44.62% -23.24% -68.79%
Profit (Net Income) Margin		 -1.09% 2.97% 28.99% 44.64% -24.95% -70.54%
Tax Burden Percent		 -132.58% 50.72% 86.75% 100.04% 107.33% 102.54%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 232.58% 49.28% 13.25% -0.04% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 30.01% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 28.36% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -23.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 7.01% 155.78% 46,642.86% -150.08% -152.88%
Cash Return on Invested Capital (CROIC)		 0.00% -169.99% 0.00% 0.00% 0.00% -3,180.15%
Operating Return on Assets (OROA)		 0.00% 3.13% 23.38% 32.50% -16.14% -45.12%
Return on Assets (ROA)		 0.00% 1.59% 20.28% 32.51% -17.33% -46.26%
Return on Common Equity (ROCE)		 0.00% 2.71% -16.22% 46,642.86% -150.08% -152.88%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.06% -97.34% 163.55% -237.05% -84.22%
Net Operating Profit after Tax (NOPAT)		 2.02 4.68 12 1.04 23 40
NOPAT Margin		 1.17% 2.40% 4.87% 0.39% 7.16% 9.93%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.65% 42.46% 79.74% -50.73% -109.97%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 1.41% 68.01% 11.85%
Cost of Revenue to Revenue		 20.85% 19.43% 17.28% 18.75% 16.37% 15.60%
SG&A Expenses to Revenue		 17.09% 16.49% 19.47% 15.09% 13.36% 12.69%
R&D to Revenue		 27.10% 27.90% 26.62% 29.79% 25.96% 24.53%
Operating Expenses to Revenue		 80.04% 75.84% 77.10% 80.86% 73.40% 70.21%
Earnings before Interest and Taxes (EBIT)		 1.42 11 82 121 -76 -276
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5.49 17 89 130 -67 -268
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 11.13 49.28 13.46
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 22.97 0.00 15.28
Price to Revenue (P/Rev)		 0.00 0.00 0.00 3.04 5.19 11.27
Price to Earnings (P/E)		 0.00 0.00 0.00 6.80 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 14.70% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 705.59
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 2.47 4.40 10.45
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 5.15 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 5.53 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 639.25 61.42 105.25
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 32.45 14.00 31.72
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 8.63 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.81 -3.05 -579.90 -3.81 -1.59
Leverage Ratio		 0.00 2.21 7.68 1,434.51 8.66 3.30
Compound Leverage Factor		 0.00 2.21 7.68 1,434.51 8.66 3.30
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 61.33% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 38.67% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 4.11 2.86 7.05
Noncontrolling Interest Sharing Ratio		 0.00% 61.33% 110.41% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 2.03 1.46 1.42 1.66 1.92
Quick Ratio		 0.00 1.22 1.14 1.02 1.20 1.27
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -26 262 -138 166 -189
Operating Cash Flow to CapEx		 259.83% 1,076.04% 705.38% 298.35% 1,951.02% 1,542.97%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.53 0.70 0.73 0.69 0.66
Accounts Receivable Turnover		 0.00 2.94 3.68 3.70 4.17 5.03
Inventory Turnover		 0.00 7.97 7.56 6.08 5.29 6.63
Fixed Asset Turnover		 0.00 12.10 14.99 15.91 19.61 24.40
Accounts Payable Turnover		 0.00 0.70 0.72 0.89 1.03 0.98
Days Sales Outstanding (DSO)		 0.00 124.20 99.18 98.63 87.59 72.61
Days Inventory Outstanding (DIO)		 0.00 45.81 48.31 60.01 68.97 55.04
Days Payable Outstanding (DPO)		 0.00 518.79 503.58 408.74 353.79 371.85
Cash Conversion Cycle (CCC)		 0.00 -348.78 -356.09 -250.10 -197.24 -244.19
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 31 -219 -81 -223 5.94
Invested Capital Turnover		 0.00 12.51 -2.62 -1.81 -2.14 -3.70
Increase / (Decrease) in Invested Capital		 0.00 31 -250 139 -142 229
Enterprise Value (EV)		 0.00 0.00 0.00 668 1,429 4,193
Market Capitalization		 0.00 0.00 0.00 822 1,686 4,523
Book Value per Share		 $0.00 $0.52 ($0.51) $0.39 $0.18 $1.60
Tangible Book Value per Share		 $0.00 $0.39 ($0.77) $0.19 ($0.02) $1.41
Total Capital		 0.00 165 -73 74 34 336
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -134 -146 -154 -257 -330
Capital Expenditures (CapEx)		 6.21 6.18 5.11 6.90 5.23 8.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 31 -59 -44 -60 -21
Debt-free Net Working Capital (DFNWC)		 0.00 165 87 88 168 272
Net Working Capital (NWC)		 0.00 165 87 88 168 272
Net Nonoperating Expense (NNE)		 3.89 -1.11 -59 -120 104 323
Net Nonoperating Obligations (NNO)		 0.00 -134 -146 -154 -257 -330
Total Depreciation and Amortization (D&A)		 4.08 5.88 7.01 8.82 8.91 7.70
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 15.93% -24.10% -16.31% -18.44% -5.33%
Debt-free Net Working Capital to Revenue		 0.00% 84.60% 35.18% 32.57% 51.75% 67.82%
Net Working Capital to Revenue		 0.00% 84.60% 35.18% 32.57% 51.75% 67.82%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.49 $0.00 $0.00 ($1.35)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 144.00M 0.00 0.00 209.47M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.44 $0.00 $0.00 ($1.35)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 161.54M 0.00 0.00 209.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 188.54M 0.00 0.00 239.47M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.06 4.68 12 0.73 23 40
Normalized NOPAT Margin		 -0.62% 2.40% 4.87% 0.27% 7.16% 9.93%
Pre Tax Income Margin		 0.82% 5.85% 33.42% 44.62% -23.24% -68.79%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 -1,332.62% 172.98% 140.06% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -1,375.69% 174.45% 140.06% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Cellebrite DI

No quarterly metrics and ratios for Cellebrite DI are available.

Frequently Asked Questions About Cellebrite DI's Financials

When does Cellebrite DI's financial year end?

According to the most recent income statement we have on file, Cellebrite DI's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Cellebrite DI's net income changed over the last 5 years?

Cellebrite DI's net income appears to be on an upward trend, with a most recent value of -$283.01 million in 2024, rising from -$1.88 million in 2019. The previous period was -$81.10 million in 2023.

What is Cellebrite DI's operating income?
Cellebrite DI's total operating income in 2024 was $56.91 million, based on the following breakdown:
  • Total Gross Profit: $338.61 million
  • Total Operating Expenses: $281.70 million
How has Cellebrite DI revenue changed over the last 5 years?

Over the last 5 years, Cellebrite DI's total revenue changed from $171.85 million in 2019 to $401.20 million in 2024, a change of 133.5%.

How much debt does Cellebrite DI have?

Cellebrite DI's total liabilities were at $354.55 million at the end of 2024, a 28.9% decrease from 2023, and a 77.8% increase since 2020.

How much cash does Cellebrite DI have?

In the past 4 years, Cellebrite DI's cash and equivalents has ranged from $87.65 million in 2022 to $191.66 million in 2024, and is currently $191.66 million as of their latest financial filing in 2024.

How has Cellebrite DI's book value per share changed over the last 5 years?

Over the last 5 years, Cellebrite DI's book value per share changed from 0.00 in 2019 to 1.60 in 2024, a change of 160.4%.


Related Companies

This page (NASDAQ:CLBT) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
The Exact July Date the AI Correction Will End?
AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...
Brownstone Research | Sponsored
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
Trump’s treachery
Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...
Porter & Company | Sponsored